These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16111789)

  • 1. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic family-specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections.
    Ekala MT; Jouin H; Lekoulou F; Mercereau-Puijalon O; Ntoumi F
    Clin Exp Immunol; 2002 Aug; 129(2):326-31. PubMed ID: 12165090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
    Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.
    Metzger WG; Okenu DM; Cavanagh DR; Robinson JV; Bojang KA; Weiss HA; McBride JS; Greenwood BM; Conway DJ
    Parasite Immunol; 2003 Jun; 25(6):307-12. PubMed ID: 14507328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
    Tonhosolo R; Wunderlich G; Ferreira MU
    J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.
    Krishnarjuna B; Andrew D; MacRaild CA; Morales RA; Beeson JG; Anders RF; Richards JS; Norton RS
    Sci Rep; 2016 Feb; 6():20613. PubMed ID: 26865062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
    Taylor RR; Allen SJ; Greenwood BM; Riley EM
    Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.
    Polley SD; Mwangi T; Kocken CH; Thomas AW; Dutta S; Lanar DE; Remarque E; Ross A; Williams TN; Mwambingu G; Lowe B; Conway DJ; Marsh K
    Vaccine; 2004 Dec; 23(5):718-28. PubMed ID: 15542195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell trait carriage: imbalanced distribution of IgG subclass antibodies reactive to Plasmodium falciparum family-specific MSP2 peptides in serum samples from Gabonese children.
    Ntoumi F; Ekala MT; Makuwa M; Lekoulou F; Mercereau-Puijalon O; Deloron P
    Immunol Lett; 2002 Oct; 84(1):9-16. PubMed ID: 12161278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.
    Terheggen U; Drew DR; Hodder AN; Cross NJ; Mugyenyi CK; Barry AE; Anders RF; Dutta S; Osier FH; Elliott SR; Senn N; Stanisic DI; Marsh K; Siba PM; Mueller I; Richards JS; Beeson JG
    BMC Med; 2014 Oct; 12():183. PubMed ID: 25319190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
    Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
    PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.
    Osier FH; Murungi LM; Fegan G; Tuju J; Tetteh KK; Bull PC; Conway DJ; Marsh K
    Parasite Immunol; 2010 Mar; 32(3):193-201. PubMed ID: 20398182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
    Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
    Pinder M; Sutherland CJ; Sisay-Joof F; Ismaili J; McCall MB; Ord R; Hallett R; Holder AA; Milligan P
    Infect Immun; 2006 May; 74(5):2887-93. PubMed ID: 16622227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antigens for a multicomponent blood-stage malaria vaccine.
    Osier FH; Mackinnon MJ; Crosnier C; Fegan G; Kamuyu G; Wanaguru M; Ogada E; McDade B; Rayner JC; Wright GJ; Marsh K
    Sci Transl Med; 2014 Jul; 6(247):247ra102. PubMed ID: 25080477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
    Dodoo D; Atuguba F; Bosomprah S; Ansah NA; Ansah P; Lamptey H; Egyir B; Oduro AR; Gyan B; Hodgson A; Koram KA
    Malar J; 2011 May; 10():108. PubMed ID: 21529376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
    Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
    Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.